MARSHALL WACE, LLP - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$53,153,704
-16.4%
334,279
-25.6%
0.11%
-12.9%
Q2 2023$63,584,571
+102.8%
449,488
+141.4%
0.12%
+85.1%
Q1 2023$31,353,515
+193.2%
186,229
+194.9%
0.07%
+179.2%
Q4 2022$10,692,096
-70.6%
63,151
-67.5%
0.02%
-70.0%
Q3 2022$36,359,000
-40.0%
194,315
-47.9%
0.08%
-36.0%
Q2 2022$60,554,000
-11.6%
372,877
+2.4%
0.12%
-3.8%
Q1 2022$68,511,000
-30.9%
364,247
-2.8%
0.13%
-29.0%
Q4 2021$99,217,000
-34.0%
374,633
-28.0%
0.18%
-70.7%
Q3 2021$150,312,000
+7.1%
520,130
-26.0%
0.62%
-1.7%
Q2 2021$140,315,000
-23.5%
702,914
-25.5%
0.64%
-24.5%
Q1 2021$183,471,000
-35.4%
943,724
-36.3%
0.84%
-45.3%
Q4 2020$283,857,000
+112.0%
1,481,280
+63.2%
1.54%
+79.5%
Q3 2020$133,919,000
+68.5%
907,676
+41.1%
0.86%
+53.9%
Q2 2020$79,495,000
+45.9%
643,113
+13.9%
0.56%
+2.4%
Q1 2020$54,498,000
+11022.0%
564,512
+8741.2%
0.54%
+13500.0%
Q3 2019$490,000
-94.8%
6,385
-94.2%
0.00%
-94.9%
Q2 2019$9,445,000
+4212.8%
109,886
+2538.3%
0.08%
+3800.0%
Q4 2018$219,000
-97.9%
4,165
-98.8%
0.00%
-97.1%
Q4 2016$10,456,000
-2.7%
339,257
-4.7%
0.07%
-9.2%
Q3 2016$10,745,000
+444.3%
355,898
+393.3%
0.08%
+347.1%
Q2 2016$1,974,000
-44.2%
72,152
-38.1%
0.02%
-63.0%
Q1 2015$3,538,000
-34.1%
116,524
-57.0%
0.05%
-35.2%
Q4 2014$5,366,000
+30.7%
271,005
+31.4%
0.07%
+20.3%
Q3 2014$4,106,000
+2.3%
206,241
+17.2%
0.06%0.0%
Q2 2014$4,012,000176,0210.06%
Other shareholders
REPLIGEN CORP shareholders Q4 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders